Study On The Profit Model Of Kanion Pharmaceutical

The deepening of the aging population and the improvement of people's health care awareness have led to the good development of the pharmaceutical manufacturing industry.At the same time,the "healthy China" strategy formulated by the state is in line with the pharmaceutical policies in the pharmaceutical industry,such as institutional reform,basic drug catalog adjustment,priority review of innovative drugs,volume purchase,consistency evaluation,rational drug use monitoring,etc.,and the pharmaceutical manufacturing industry is accelerating industrial restructuring and upgrading.According to the data of the National Bureau of statistics,in 2018,pharmaceutical manufacturing enterprises above Designated Size achieved an operating revenue of 2.40 trillion yuan,with a cumulative growth of 12.4%,and a total profit of 0.31 trillion yuan,with a cumulative growth of 9.5%.There are two kinds of medical systems in today's society,one is traditional Chinese medicine,the other is western medicine.Traditional Chinese medicine plays a unique role in the concept of "recuperation,health preservation and health care" and in dealing with complex health problems such as chronic diseases.However,in the analysis of domestic pharmaceutical manufacturing market,the enterprises are small in scale,most of which are mainly generic drugs with small cost and low price.In addition,the market of generic drugs is highly competitive and the enterprises lack core competitiveness.Kanion pharmaceutical industry is a traditional Chinese medicine enterprise that breaks through the encirclement of the generic pharmaceutical market and attracts the attention of the industry.Kanion pharmaceutical industry not only pays attention to the R & D and sales management of traditional Chinese medicine,accelerates the structural adjustment,and becomes a leading enterprise in the manufacturing industry of traditional Chinese medicine,but also plays a leading role in fulfilling social responsibilities.Taking Kanion pharmaceutical industry as a case,it is helpful to deepen the understanding of pharmaceutical manufacturing industry.Based on the literature review of the profit model at home and abroad,this paper takes Kanion pharmaceutical,the leading enterprise in the pharmaceutical manufacturing industry,as the research object,analyzes the characteristics of the profit model of KanionPharmaceutical by means of case analysis,comparative analysis,quantitative and qualitative analysis.The purpose of this paper is to study the advantages of the profit model of Kanion pharmaceutical,and play a reference role in the healthy and sustainable development of the same industry At the same time,some suggestions were put forward for the future development of Kanion pharmaceutical industry.The specific contents are as follows:In the theoretical part,firstly,it briefly introduces the research background,research significance and research status at home and abroad.Secondly,it outlines the basic research ideas,framework and research methods used in this paper.Finally,it summarizes the meaning and components of profit model,and introduces the industrial chain theory used in this paper The theory of capital value and the theory of strategy provide theoretical support for the case analysis of the article.In the practice part,firstly,it introduces the main business and operation of Kanion pharmaceutical,secondly,it analyzes the profit model of Kanion pharmaceutical,thirdly,it evaluates the profit model of Kanion pharmaceutical,including the evaluation from the perspective of financial indicators and sustainable development.Finally,it thinks that the profit model is suitable for the development of Kanion pharmaceutical,summarizes its advantages and provides reference for other enterprises And put forward optimization suggestions.